ESMO Spotlight: Flagship ADCs move into early-stage cancer to validate chemo-displacement ambitions

ESMO 2025; antibody-drug conjugates; ADCs; early-stage cancer; chemo-displacement; trastuzumab deruxtecan; ENHERTU; datopotamab deruxtecan; DATROWAY; breast cancer; HER2-positive; triple-negative breast cancer; biomarkers; toxicity management

Personalizing Metabolic Care with Digital Twins: Recent Developments

digital twins; metabolic health; AI healthcare; personalized medicine; biomarkers; diabetes management; obesity reversal; real-time guidance; GLP-1; Twin Health

Trump Administration Unveils Health Data Sharing Scheme Backed by Apple, Amazon, and Others

Trump administration; health data sharing; CMS Interoperability Framework; Apple; Amazon; digital health records; patient data; privacy; tech partnerships

Lark Health Launches LarkVantage: AI-Powered Platform to Manage GLP-1 Costs

Lark Health; LarkVantage; GLP-1 cost management; AI healthcare; prior authorization; utilization management; PBM; health plans; weight management; Matthew Gibbs

Eli Lilly Strikes $650M Deal with Juvena to Develop Muscle-Boosting Drugs

Eli Lilly; Juvena Therapeutics; muscle-boosting drugs; AI drug discovery; muscle health; biotech collaboration; stem cell secreted proteins; drug development; obesity management; $650 million deal

Trump Administration Cancels Major Federal Funding for Moderna’s Bird Flu Vaccine

Trump administration; Moderna; bird flu vaccine; HHS; funding cancellation; mRNA vaccine; pandemic preparedness; H5 avian influenza

Chronic care startup Omada Health files to go public

Chronic care management, virtual care, IPO, digital health, diabetes management, cardiometabolic health, hypertension, musculoskeletal conditions, revenue growth, Hinge Health